General Information of the Cell Line
Cell Line ID
CL000475
Cell Line Name
SK-N-BE(2)-C
Synonyms
SK-N-BE(2)C
SK-N-BE-2c
SK-N-BE2(c)
SK-N-BE(2C)
SK-N-BE(2c)
SK-N-BE2C
SK_N_BE2C
SKNBE2C
SKNBE(2c)
BE(2)-C
BE(2)C
Be(2)C
BE2-C
BE2_C
Be2-C
BE2C
Be2C
Category
Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_0529
Tissue Information
Bone marrow
Disease
Neuroblastoma (NCIt: C3270)
Neuroblastoma (ORDO: Orphanet_635)
Map of Molecular Bioactivity Related to the Cell Line
Map of Molecular Bioactivity Related to the Cell Line

Cell Line
Protein
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Cell Line
Protein ID: PT01020, Beta-secretase 1
Compound ID Compound Name Compound Formula
CP0143562
N-[3-[(4S)-2-amino-4-methyl-5,6-dihydro-1,3-thiazin-4-yl]-4-fluorophenyl]-5-cyanopyridine-2-carboxamide
   Show/Hide
C18H16FN5OS
 1
1
IC50 = 0.93 nM
   TI
   LI
   LO
   TS
CP0206016
N-[3-[(4S)-2-amino-4-methyl-5,6-dihydro-1,3-thiazin-4-yl]-4-fluorophenyl]-5-chloropyridine-2-carboxamide
   Show/Hide
C17H16ClFN4OS
 1
1
IC50 = 0.93 nM
   TI
   LI
   LO
   TS
CP0559105
N-[3-[(9R)-7-amino-2,2-difluoro-9-methyl-6-thia-8-azaspiro[3.5]non-7-en-9-yl]-4-fluorophenyl]-5-(fluoromethoxy)pyrazine-2-carboxamide
   Show/Hide
C20H19F4N5O2S
 1
1
IC50 = 1.2 nM
   TI
   LI
   LO
   TS
CP0137792
US9751886, Compound 2
   Show/Hide
C19H15FN8O
 1
1
IC50 = 1.202 nM
   TI
   LI
   LO
   TS
CP0135177
N-[3-[(3R)-1-amino-3-methyl-4H-pyrrolo[1,2-a]pyrazin-3-yl]-4-fluorophenyl]-5-cyanopyridine-2-carboxamide
   Show/Hide
C21H17FN6O
 1
1
IC50 = 1.318 nM
   TI
   LI
   LO
   TS
CP0484297
N-[3-[(4S)-2-amino-4-methyl-5,6-dihydro-1,3-thiazin-4-yl]-4-fluorophenyl]-5-(fluoromethoxy)pyrazine-2-carboxamide
   Show/Hide
C17H17F2N5O2S
 1
1
IC50 = 1.8 nM
   TI
   LI
   LO
   TS
CP0364143
N-[3-[(4S,5R)-2-amino-4-methyl-5-(oxan-4-yl)-5,6-dihydro-1,3-thiazin-4-yl]-4-fluorophenyl]-5-(fluoromethoxy)pyrazine-2-carboxamide
   Show/Hide
C22H25F2N5O3S
 1
1
IC50 = 2 nM
   TI
   LI
   LO
   TS
CP0508363
N-[3-[(4S,5S)-2-amino-4-methyl-5-phenyl-5,6-dihydro-1,3-thiazin-4-yl]-4-fluorophenyl]-5-(fluoromethoxy)pyrazine-2-carboxamide
   Show/Hide
C23H21F2N5O2S
 1
1
IC50 = 2 nM
   TI
   LI
   LO
   TS
CP0243093
N-[3-[(6R)-4-amino-6-methyl-7H-pyrazolo[1,5-a]pyrazin-6-yl]phenyl]-5-cyanopyridine-2-carboxamide
   Show/Hide
C20H17N7O
 1
1
IC50 = 2.188 nM
   TI
   LI
   LO
   TS
CP0426439
N-[3-[(4S,5R)-2-amino-4-methyl-5-phenyl-5,6-dihydro-1,3-thiazin-4-yl]-4-fluorophenyl]-5-(fluoromethoxy)pyrazine-2-carboxamide
   Show/Hide
C23H21F2N5O2S
 1
1
IC50 = 2.3 nM
   TI
   LI
   LO
   TS
CP0075806
N-[3-[(5R)-3-amino-9,9-difluoro-5-methyl-2-thia-4-azaspiro[5.5]undec-3-en-5-yl]-4-fluorophenyl]-5-(fluoromethoxy)pyrazine-2-carboxamide
   Show/Hide
C22H23F4N5O2S
 1
1
IC50 = 4.3 nM
   TI
   LI
   LO
   TS
CP0426438
N-[3-[(4R,5R)-2-amino-5-methoxy-4-methyl-5,6-dihydro-1,3-thiazin-4-yl]-4-fluorophenyl]-5-(fluoromethoxy)pyrazine-2-carboxamide
   Show/Hide
C18H19F2N5O3S
 1
1
IC50 = 4.5 nM
   TI
   LI
   LO
   TS
CP0365697
N-[3-[(2R,3R)-5-amino-2-(difluoromethyl)-3-methyl-2,6-dihydro-1,4-oxazin-3-yl]-4-fluorophenyl]-5-methoxypyrazine-2-carboxamide
   Show/Hide
C18H18F3N5O3
 1
1
IC50 = 4.9 nM
   TI
   LI
   LO
   TS
CP0124717
N-[3-[(4S)-2-amino-4-methyl-5,6-dihydro-1,3-thiazin-4-yl]-4-fluorophenyl]-5-methoxypyrazine-2-carboxamide
   Show/Hide
C17H18FN5O2S
 1
1
IC50 = 5.4 nM
   TI
   LI
   LO
   TS
CP0689440
N-{3-[(2R,3R)-5-Amino-3-methyl-2-(trifluoromethyl)-3,6-dihydro-2H-1,4-oxazin-3-yl]-4-fluorophenyl}-5-cyanopyridine-2-carboxamide
   Show/Hide
C19H15F4N5O2
 1
1
IC50 = 6 nM
   TI
   LI
   LO
   TS
CP0124631
N-[3-[(6R)-8-amino-6-methyl-5H-imidazo[1,2-a]pyrazin-6-yl]-4-fluorophenyl]-5-cyanopyridine-2-carboxamide
   Show/Hide
C20H16FN7O
 1
1
IC50 = 6.31 nM
   TI
   LI
   LO
   TS
CP0471898
N-[3-[(2R,3R)-5-amino-3-methyl-2-(trifluoromethyl)-2,6-dihydro-1,4-oxazin-3-yl]-4-fluorophenyl]-3-chloro-5-cyanopyridine-2-carboxamide
   Show/Hide
C19H14ClF4N5O2
 1
1
IC50 = 6.4 nM
   TI
   LI
   LO
   TS
CP0135175
N-[3-[(6R)-8-amino-6-methyl-5H-[1,2,4]triazolo[4,3-a]pyrazin-6-yl]-4-fluorophenyl]-5-cyanopyridine-2-carboxamide
   Show/Hide
C19H15FN8O
 1
1
IC50 = 6.607 nM
   TI
   LI
   LO
   TS
CP0265376
N-[3-[(5R)-3-amino-5-methyl-9-oxa-2-thia-4-azaspiro[5.5]undec-3-en-5-yl]-4-fluorophenyl]-5-(fluoromethoxy)pyrazine-2-carboxamide
   Show/Hide
C21H23F2N5O3S
 1
1
IC50 = 6.8 nM
   TI
   LI
   LO
   TS
CP0262950
N-[3-[(2R,3R)-5-amino-3-methyl-2-(trifluoromethyl)-2,6-dihydro-1,4-oxazin-3-yl]-4-fluorophenyl]-5-chloropyridine-2-carboxamide
   Show/Hide
C18H15ClF4N4O2
 1
1
IC50 = 7.2 nM
   TI
   LI
   LO
   TS
CP0484295
N-[3-[(4S)-2-amino-4-methyl-5,6-dihydro-1,3-thiazin-4-yl]-4-fluorophenyl]-5-(difluoromethyl)pyrazine-2-carboxamide
   Show/Hide
C17H16F3N5OS
 1
1
IC50 = 7.2 nM
   TI
   LI
   LO
   TS
CP0067274
N-[3-[(2R,3R)-5-amino-2-fluoro-3-methyl-2,6-dihydro-1,4-oxazin-3-yl]-4-fluorophenyl]-5-cyanopyridine-2-carboxamide
   Show/Hide
C18H15F2N5O2
 1
1
IC50 = 8.3 nM
   TI
   LI
   LO
   TS
CP0082231
N-[3-[(6R)-8-amino-6-methyl-5H-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-4-fluorophenyl]-5-cyanopyridine-2-carboxamide
   Show/Hide
C19H15FN8O
 1
1
IC50 = 9.772 nM
   TI
   LI
   LO
   TS
CP0243092
N-[3-[(6R)-8-amino-6-methyl-5H-imidazo[1,2-a]pyrazin-6-yl]-4-fluorophenyl]-5-chloropyridine-2-carboxamide
   Show/Hide
C19H16ClFN6O
 1
1
IC50 = 10.47 nM
   TI
   LI
   LO
   TS
CP0465046
N-[3-[(2R,3R)-5-amino-2-fluoro-3-methyl-2,6-dihydro-1,4-oxazin-3-yl]-4-fluorophenyl]-5-cyano-3-fluoropyridine-2-carboxamide
   Show/Hide
C18H14F3N5O2
 1
1
IC50 = 12.2 nM
   TI
   LI
   LO
   TS
CP0478213
N-[3-[(2R,3R)-5-amino-3-methyl-2-(trifluoromethyl)-2,6-dihydro-1,4-oxazin-3-yl]-4-fluorophenyl]-5-(2-methoxyethoxy)pyrazine-2-carboxamide
   Show/Hide
C20H21F4N5O4
 1
1
IC50 = 12.5 nM
   TI
   LI
   LO
   TS
CP0198194
N-[3-[(5R)-3-amino-5-methyl-9,9-dioxo-2,9lambda6-dithia-4-azaspiro[5.5]undec-3-en-5-yl]-4-fluorophenyl]-5-(fluoromethoxy)pyrazine-2-carboxamide
   Show/Hide
C21H23F2N5O4S2
 1
1
IC50 = 13 nM
   TI
   LI
   LO
   TS
CP0249063
N-[3-[(4S)-2-amino-4-methyl-5,6-dihydro-1,3-thiazin-4-yl]-4-fluorophenyl]-5-(2,2,2-trifluoroethoxy)pyrazine-2-carboxamide
   Show/Hide
C18H17F4N5O2S
 1
1
IC50 = 13 nM
   TI
   LI
   LO
   TS
CP0074572
N-[3-[(2R,3R)-5-amino-2-fluoro-3-methyl-2,6-dihydro-1,4-oxazin-3-yl]-4-fluorophenyl]-5-methoxypyrazine-2-carboxamide
   Show/Hide
C17H17F2N5O3
 1
1
IC50 = 13.2 nM
   TI
   LI
   LO
   TS
CP0331661
N-[3-[(2R,3R)-5-amino-2-fluoro-3-methyl-2,6-dihydro-1,4-oxazin-3-yl]-4-fluorophenyl]-3-chloro-5-cyanopyridine-2-carboxamide
   Show/Hide
C18H14ClF2N5O2
 1
1
IC50 = 15.5 nM
   TI
   LI
   LO
   TS
CP0143564
N-[3-[(4S)-2-amino-4-methyl-5,6-dihydro-1,3-thiazin-4-yl]-4-fluorophenyl]-5-fluoropyridine-2-carboxamide
   Show/Hide
C17H16F2N4OS
 1
1
IC50 = 16 nM
   TI
   LI
   LO
   TS
CP0252314
N-[3-[(6R)-8-amino-6-methyl-5H-imidazo[1,5-a]pyrazin-6-yl]-4-fluorophenyl]-5-cyanopyridine-2-carboxamide
   Show/Hide
C20H16FN7O
 1
1
IC50 = 18.2 nM
   TI
   LI
   LO
   TS
CP0365698
N-[3-[(2R,3R)-5-amino-3-methyl-2-(trifluoromethyl)-2,6-dihydro-1,4-oxazin-3-yl]-4-fluorophenyl]-5-(2,2,2-trifluoroethoxy)pyrazine-2-carboxamide
   Show/Hide
C19H16F7N5O3
 1
1
IC50 = 20.9 nM
   TI
   LI
   LO
   TS
CP0464951
N-[3-[(2R,3R)-5-amino-3-methyl-2-(trifluoromethyl)-2,6-dihydro-1,4-oxazin-3-yl]-4-fluorophenyl]-5-methoxypyrazine-2-carboxamide
   Show/Hide
C18H17F4N5O3
 1
1
IC50 = 27.7 nM
   TI
   LI
   LO
   TS
CP0547265
N-[3-[(3R)-5-amino-1,3-dimethyl-6-oxo-2H-pyrazin-3-yl]-4-fluorophenyl]-5-chloropyridine-2-carboxamide
   Show/Hide
C18H17ClFN5O2
 1
1
IC50 = 28.18 nM
   TI
   LI
   LO
   TS
CP0365696
N-[3-[(5R)-3-amino-6-(difluoromethylidene)-5-methyl-2H-1,4-oxazin-5-yl]-4-fluorophenyl]-5-methoxypyrazine-2-carboxamide
   Show/Hide
C18H16F3N5O3
 1
1
IC50 = 35.1 nM
   TI
   LI
   LO
   TS
CP0241298
N-[3-[(3R)-5-amino-3-methyl-2,6-dihydro-1,4-oxazin-3-yl]-4-fluorophenyl]-3-cyanopyridine-2-carboxamide
   Show/Hide
C18H16FN5O2
 1
1
IC50 = 40.3 nM
   TI
   LI
   LO
   TS
CP0241297
N-[3-[(2R,3R)-5-amino-3-methyl-2-(trifluoromethyl)-2,6-dihydro-1,4-oxazin-3-yl]-4-fluorophenyl]-5-(1,1,2,2,2-pentafluoroethoxy)pyrazine-2-carboxamide
   Show/Hide
C19H14F9N5O3
 1
1
IC50 = 49 nM
   TI
   LI
   LO
   TS
CP0153818
N-[3-[(6R)-8-amino-6-methyl-5H-tetrazolo[1,5-a]pyrazin-6-yl]-4-fluorophenyl]-5-cyanopyridine-2-carboxamide
   Show/Hide
C18H14FN9O
 1
1
IC50 = 97.72 nM
   TI
   LI
   LO
   TS
CP0365700
N-[3-[(2R,3R)-5-amino-3-methyl-2-(trifluoromethyl)-2,6-dihydro-1,4-oxazin-3-yl]-4-fluorophenyl]-5-(azetidin-1-yl)pyrazine-2-carboxamide
   Show/Hide
C20H20F4N6O2
 1
1
IC50 = 115 nM
   TI
   LI
   LO
   TS
CP0548266
6-[(E)-2-[3-[(3R)-5-amino-3-methyl-2,6-dihydro-1,4-oxazin-3-yl]-4-fluoroanilino]ethenyl]pyridine-3-carbonitrile
   Show/Hide
C19H18FN5O
 1
1
IC50 = 251 nM
   TI
   LI
   LO
   TS
CP0365699
N-[3-[(2R,3R)-5-amino-3-methyl-2-(trifluoromethyl)-2,6-dihydro-1,4-oxazin-3-yl]-4-fluorophenyl]-5-(cyclopropylamino)pyrazine-2-carboxamide
   Show/Hide
C20H20F4N6O2
 1
1
IC50 = 603 nM
   TI
   LI
   LO
   TS
CP0365701
N-[3-[(3R)-5-amino-3-methyl-2,6-dihydro-1,4-oxazin-3-yl]-4-fluorophenyl]pyrimidine-5-carboxamide
   Show/Hide
C16H16FN5O2
 1
1
IC50 = 631 nM
   TI
   LI
   LO
   TS
CP0262951
N-[3-[(2R,3R)-5-amino-3-methyl-2-(trifluoromethyl)-2,6-dihydro-1,4-oxazin-3-yl]-4-fluorophenyl]-5-(2,2,2-trifluoroethylamino)pyrazine-2-carboxamide
   Show/Hide
C19H17F7N6O2
 1
1
IC50 = 4500 nM
   TI
   LI
   LO
   TS
Protein family and CMB statistics Related to the Cell Line
Cell Lines Derived from the same Tissue Source (Bone marrow)
Cell Line Name Organism Disease
NB4 Homo sapiens (Human) Acute promyelocytic leukemia with PML-RARA
UT-7/Epo Homo sapiens (Human) Adult acute megakaryoblastic leukemia
UT-7 Homo sapiens (Human) Adult acute megakaryoblastic leukemia
KG-1 Homo sapiens (Human) Adult acute myeloid leukemia
KG-1a Homo sapiens (Human) Adult acute myeloid leukemia
RS4;11 Homo sapiens (Human) Adult B acute lymphoblastic leukemia
Rh30 Homo sapiens (Human) Alveolar rhabdomyosarcoma
MEG-01 Homo sapiens (Human) Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
697 Homo sapiens (Human) Childhood B acute lymphoblastic leukemia
SUP-B15 Homo sapiens (Human) Childhood B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
HAP1 Homo sapiens (Human) Chronic myelogenous leukemia, BCR-ABL1 positive
OCI-Ly1 Homo sapiens (Human) Diffuse large B-cell lymphoma
OCI-Ly3 Homo sapiens (Human) Diffuse large B-cell lymphoma activated B-cell type
TMD8 Homo sapiens (Human) Diffuse large B-cell lymphoma activated B-cell type
OCI-Ly19 Homo sapiens (Human) Diffuse large B-cell lymphoma germinal center B-cell type
TF-1 Homo sapiens (Human) Erythroleukemia
L-540 Homo sapiens (Human) Hodgkin lymphoma
NCI-H345 Homo sapiens (Human) Lung small cell carcinoma
NCI-H526 Homo sapiens (Human) Lung small cell carcinoma
Z-138 Homo sapiens (Human) Mantle cell lymphoma
CAL-1 [Human melanoma] Homo sapiens (Human) Melanoma
SH-SY5Y Homo sapiens (Human) Neuroblastoma
SH-EP1 Homo sapiens (Human) Neuroblastoma
SK-N-BE(2) Homo sapiens (Human) Neuroblastoma
SK-N-SH Homo sapiens (Human) Neuroblastoma
SK-N-BE(1) Homo sapiens (Human) Neuroblastoma
SK-N-AS Homo sapiens (Human) Neuroblastoma
GI-CA-N Homo sapiens (Human) Neuroblastoma
LSCC-HD11 Gallus gallus (Chicken) -
IM-9 Homo sapiens (Human) -
LAD 2 Homo sapiens (Human) -
UE6E7T-2 Homo sapiens (Human) -
RBC Homo sapiens (Human) -
Ba/F3 Mus musculus (Mouse) -
FDC-P1 Mus musculus (Mouse) -
S21 Mus musculus (Mouse) -
ANA-1 [Mouse macrophage] Mus musculus (Mouse) -
Y16 Mus musculus (Mouse) -
32D Mus musculus (Mouse) -
Ba/F3 FLT3-ITD Mus musculus (Mouse) -
Ba/F3 c-Kit D816V Mus musculus (Mouse) -
Bone marrow macrophage immortalized C57BL/6 Mus musculus (Mouse) -
BaF3-BCL Mus musculus (Mouse) -
Ba/F3 NPM-ALK Mus musculus (Mouse) -
Bone marrow macrophage immortalized BALB/c Mus musculus (Mouse) -